Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T17:27:00.191Z.
Calculation as of: 2026-10-06T17:27:00.191Z.
Quote observation: 2026-10-06T17:25:16.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f23401f377ae0c42cb4058dfce1620411e9c781823cb8ffdb9eedba1333334c1
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2014-03-27.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
FREE CASH FLOW YIELD AVG TTM
N/A
FREE CASH FLOW YIELD AVG 3Y
N/A
FREE CASH FLOW YIELD AVG 5Y
N/A
FREE CASH FLOW YIELD AVG 10Y
N/A
FREE CASH FLOW YIELD AVG 15Y
N/A
FREE CASH FLOW YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Iovance Biotherapeutics, Inc.
Market Cap
$5.90B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.89B
Free Cash Flow Yield
2.23%
TTM Avg
1.45%
3Y Avg
2.90%
5Y Avg
4.76%
Market Cap
$5.74B
Free Cash Flow Yield
3.19%
TTM Avg
3.21%
3Y Avg
2.24%
5Y Avg
2.33%
Market Cap
$6.19B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.52B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Iovance Biotherapeutics, Inc. (IOVA) | $5.90B | N/A | N/A | N/A | N/A |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.89B | 2.23% | 1.45% | 2.90% | 4.76% |
| GRAIL Inc. (GRAL)vs › | $5.99B | N/A | N/A | N/A | N/A |
| Kodiak Sciences Inc. (KOD)vs › | $5.77B | N/A | N/A | N/A | N/A |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.74B | 3.19% | 3.21% | 2.24% | 2.33% |
| CG Oncology Inc. (CGON)vs › | $5.61B | N/A | N/A | N/A | N/A |
| Rhythm Pharmaceuticals, Inc. (RYTM)vs › | $6.19B | N/A | N/A | N/A | N/A |
| RadNet, Inc. (RDNT)vs › | $5.53B | N/A | 1.33% | 1.38% | 3.12% |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.52B | N/A | N/A | N/A | N/A |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.48B | 1.28% | 4.83% | 9.01% | 13.21% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | FREE CASH FLOW YIELD |
|---|---|
| 2014-03-27 | 84.07% |
| 2014-03-26 | 82.72% |
| 2014-03-25 | 82.01% |
| 2014-03-24 | 84.50% |
| 2014-03-21 | 78.17% |
| 2014-03-20 | 75.10% |
| 2014-03-19 | 79.57% |
| 2014-03-18 | 82.31% |
| 2014-03-17 | 84.07% |
| 2014-03-14 | 87.95% |
| 2014-03-13 | 84.82% |
| 2014-03-12 | 80.63% |
| 2014-03-11 | 79.57% |
| 2014-03-10 | 74.68% |
| 2014-03-07 | 76.83% |
| 2014-03-06 | 83.65% |
| 2014-03-05 | 81.02% |
| 2014-03-04 | 97.72% |
| 2014-03-03 | 109.57% |
| 2014-02-28 | 121.09% |
| 2014-02-27 | 113.10% |
| 2014-02-26 | 113.87% |
| 2014-02-25 | 112.34% |
| 2014-02-24 | 112.34% |
| 2014-02-21 | 119.36% |
| 2014-02-20 | 122.87% |
| 2014-02-19 | 127.31% |
| 2014-02-18 | 124.93% |
| 2014-02-14 | 115.24% |
| 2014-02-13 | 103.79% |
| 2014-02-12 | 111.40% |
| 2014-02-11 | 118.30% |
| 2014-02-10 | 127.31% |
| 2014-02-07 | 136.69% |
| 2014-02-06 | 135.03% |
| 2014-02-05 | 135.30% |
| 2014-02-04 | 133.68% |
| 2014-02-03 | 123.78% |
| 2014-01-31 | 135.58% |
| 2014-01-30 | 102.20% |
| 2014-01-29 | 102.83% |
| 2014-01-28 | 111.59% |
| 2014-01-27 | 115.44% |
| 2014-01-24 | 117.47% |
| 2014-01-23 | 117.47% |
| 2014-01-22 | 102.67% |
| 2014-01-21 | 90.32% |
| 2014-01-17 | 86.24% |
| 2014-01-16 | 83.03% |
| 2014-01-15 | 75.52% |
| 2014-01-14 | 78.63% |
| 2014-01-13 | 79.57% |
| 2014-01-10 | 83.76% |
| 2014-01-09 | 83.24% |
| 2014-01-08 | 78.54% |
| 2014-01-07 | 70.43% |
| 2014-01-06 | 69.62% |
| 2014-01-03 | 70.80% |
| 2014-01-02 | 68.55% |
| 2013-12-31 | 63.66% |
| 2013-12-30 | 60.76% |
| 2013-12-27 | 59.68% |
| 2013-12-26 | 68.91% |
| 2013-12-24 | 70.36% |
| 2013-12-23 | 70.36% |
| 2013-12-20 | 74.27% |
| 2013-12-19 | 70.36% |
| 2013-12-18 | 68.20% |
| 2013-12-17 | 70.36% |
| 2013-12-16 | 61.60% |
| 2013-12-13 | 70.36% |
| 2013-12-12 | 81.51% |
| 2013-12-11 | 77.72% |
| 2013-12-10 | 70.88% |
| 2013-12-09 | 63.06% |
| 2013-12-06 | 60.76% |
| 2013-12-05 | 64.27% |
| 2013-12-04 | 71.79% |
| 2013-12-03 | 75.95% |
| 2013-12-02 | 90.32% |
| 2013-11-29 | 79.38% |
| 2013-11-27 | 79.48% |
| 2013-11-26 | 90.32% |
| 2013-11-25 | 122.64% |
| 2013-11-22 | 133.41% |
| 2013-11-21 | 133.68% |
| 2013-11-20 | 128.54% |
| 2013-11-19 | 133.68% |
| 2013-11-18 | 99.76% |
| 2013-11-15 | 124.93% |
| 2013-11-14 | 151.39% |
| 2013-11-13 | 175.61% |
| 2013-11-12 | 183.44% |
| 2013-11-11 | 185.50% |
| 2013-11-08 | 185.50% |
| 2013-11-07 | 188.69% |
| 2013-11-06 | 188.15% |
| 2013-11-05 | 175.61% |
| 2013-11-04 | 164.63% |
| 2013-11-01 | 151.39% |
| 2013-10-31 | 138.64% |
| 2013-10-30 | 120.17% |
| 2013-10-29 | 123.09% |
| 2013-10-28 | 123.09% |
| 2013-10-25 | 121.73% |
| 2013-10-24 | 119.73% |
| 2013-10-23 | 119.73% |
| 2013-10-22 | 95.23% |
| 2013-10-21 | 97.82% |
| 2013-10-18 | 92.77% |
| 2013-10-17 | 89.83% |
| 2013-10-16 | 89.83% |
| 2013-10-15 | 89.83% |
| 2013-10-14 | 89.83% |
| 2013-10-11 | 77.00% |
| 2013-10-10 | 69.55% |
| 2013-10-09 | 59.23% |
| 2013-10-08 | 56.44% |
| 2013-10-07 | 53.90% |
| 2013-10-04 | 49.00% |
| 2013-10-03 | 56.74% |
| 2013-10-02 | 59.89% |
| 2013-10-01 | 82.92% |
| 2013-09-30 | 82.29% |
| 2013-09-27 | 106.73% |
| 2013-09-26 | 134.75% |
| 2013-09-25 | 134.75% |
| 2013-09-24 | 107.80% |
